160
Participants
Start Date
September 16, 2019
Primary Completion Date
February 1, 2021
Study Completion Date
February 1, 2021
Self-rating Questionnaires
"* Snaith-Hamilton Pleasure Scale (SHAPS; Snaith et al. 1995)~* Quick Inventory of Depressive Symptomatology (QIDS; 16 items)~* Behavioral avoidance/inhibition Scales (BIS/BAS)"
Measures of Reward processing/reinforcement learning
"* Grip Strength Effort Task (Reddy et al. 2015; in combination with EEG)~* Doors (Gambling) task (Foti and Hajcak 2009; in combination with EEG)~* Reinforcement Learning/Working Memory task (Collins et al. 2017; no EEG)"
Additional Schizophrenia-specific Questionnaires and Interviews
"* Positive and Negative Syndrome Scale (PANSS: Kay et al. 1987)~* Brief Negative Symptom Scale (BNSS; Kirkpatrick et al. 2011)"
University Hospital Frankfurt, Department of Psychiatry, Psychosomatic Medicine and Psychotherap, Frankfurt
Aristotle University of Thessaloniki, School of Medicine, Department of Clinical Pharmacology, Thessaloniki
Maastricht University, Maastricht
Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, Barcelona
Collaborators (1)
P1vital Products LTD.
UNKNOWN
Biotrial
INDUSTRY
University Hospital Frankfurt, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy
UNKNOWN
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
UNKNOWN
Aristotle University Of Thessaloniki
OTHER
Maastricht University, School for Mental Health and Neuroscience
UNKNOWN
Maastricht University
OTHER